NO20061953L - Melaninkonsentrerende hormonantagonister - Google Patents
Melaninkonsentrerende hormonantagonisterInfo
- Publication number
- NO20061953L NO20061953L NO20061953A NO20061953A NO20061953L NO 20061953 L NO20061953 L NO 20061953L NO 20061953 A NO20061953 A NO 20061953A NO 20061953 A NO20061953 A NO 20061953A NO 20061953 L NO20061953 L NO 20061953L
- Authority
- NO
- Norway
- Prior art keywords
- concentrating hormone
- hormone antagonists
- melanin concentrating
- compounds
- appetite
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/79—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Foreliggende oppfinnelse vedrører forbindelser i stand til å tjene som moderatorer av appetitt hos menneske og pattedyr og som sådan tilveiebringer et middel for å redusere kroppsmasse. Forbindelsene ifølge foreliggende oppfinnelse er selektive overfor melaninkonsentrerende hormon, og har ikke de pernisiøse bivirkningene resulterende fra forbindelser som gjensidig påvirker andre appetittrelaterte hjernereseptorer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50777303P | 2003-10-01 | 2003-10-01 | |
US53664004P | 2004-01-15 | 2004-01-15 | |
PCT/US2004/031631 WO2005033063A2 (en) | 2003-10-01 | 2004-09-24 | Melanin concentrating hormone antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061953L true NO20061953L (no) | 2006-06-13 |
Family
ID=34426018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061953A NO20061953L (no) | 2003-10-01 | 2006-05-02 | Melaninkonsentrerende hormonantagonister |
Country Status (20)
Country | Link |
---|---|
US (1) | US7304065B2 (no) |
EP (1) | EP1667958A2 (no) |
JP (1) | JP2007508303A (no) |
KR (1) | KR20060060047A (no) |
CN (1) | CN101068773A (no) |
AR (1) | AR045958A1 (no) |
AU (1) | AU2004278352B2 (no) |
BR (1) | BRPI0415051A (no) |
CA (1) | CA2540826A1 (no) |
CO (1) | CO5690589A2 (no) |
IL (1) | IL174370A0 (no) |
IS (1) | IS8360A (no) |
MA (1) | MA28079A1 (no) |
MX (1) | MXPA06003654A (no) |
NO (1) | NO20061953L (no) |
PE (1) | PE20050475A1 (no) |
RU (1) | RU2006110272A (no) |
SG (1) | SG146692A1 (no) |
TW (1) | TW200526554A (no) |
WO (1) | WO2005033063A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001160A1 (en) * | 2006-06-23 | 2008-01-03 | The Procter & Gamble Company | Melanin concentrating hormone antagonists |
PT2041093E (pt) * | 2006-06-28 | 2010-06-28 | Glaxo Group Ltd | Derivados de piperazinilo úteis no tratamento de doenças mediadas pelo receptor gpr38 |
EP2098509A4 (en) * | 2006-10-06 | 2010-04-07 | Taisho Pharmaceutical Co Ltd | 1-NAPHTHYLALKYLPIPERIDINDERIVATE |
JP2010525069A (ja) * | 2007-04-27 | 2010-07-22 | パラテック ファーマシューティカルズ インコーポレイテッド | アミノアルキルテトラサイクリン化合物の合成方法および精製方法 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
JP2011524893A (ja) * | 2008-06-18 | 2011-09-08 | ファイザー・リミテッド | ニコチンアミド誘導体 |
UY32442A (es) | 2009-02-13 | 2010-09-30 | Sanofi Aventis | Nuevos indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
AR075402A1 (es) * | 2009-02-13 | 2011-03-30 | Sanofi Aventis | Derivados heterociclicos oxigenados y/o nitrogenados de tetrahidronaftaleno, medicamentos que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad,entre otros. |
WO2011083804A1 (ja) * | 2010-01-06 | 2011-07-14 | 武田薬品工業株式会社 | インドール誘導体 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206428A (en) * | 1989-11-16 | 1993-04-27 | Tanabe Seiyaku Co., Ltd. | Tetrahydronaphthalene derivatives and preparation thereof |
ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
EP0683782A4 (en) | 1993-02-12 | 1996-03-27 | Merck & Co Inc | CLASS III ANTIARRHYTHMICS BASED ON SPIRO (2H-1-BENZOPYRANNE-2, 4 'PIPERIDINE). |
WO1994027597A1 (en) | 1993-05-21 | 1994-12-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid angiotensin ii receptor antagonists |
EP0763034A1 (en) | 1994-05-28 | 1997-03-19 | Smithkline Beecham Plc | Amide derivatives having 5ht1d-antagonist activity |
DE4438029A1 (de) * | 1994-10-25 | 1996-05-02 | Thomae Gmbh Dr K | N.N-disubstituierte Benzocycloalkylamine, ihre Salze mit verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel |
AU5147196A (en) * | 1995-03-27 | 1996-10-16 | Smithkline Beecham Plc | Bicyclic amine derivatives and their use as anti-psychotic a gents |
DE19614718A1 (de) | 1996-04-15 | 1997-10-16 | Hoechst Schering Agrevo Gmbh | Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel |
PT971878E (pt) | 1997-02-27 | 2008-07-08 | Takeda Pharmaceutical | Compostos de amina, sua produção e utilização como inibidores da produção de amilóide beta |
AU5196399A (en) * | 1998-08-11 | 2000-03-06 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
WO2001021577A2 (en) | 1999-09-20 | 2001-03-29 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
ATE479429T1 (de) | 2000-04-28 | 2010-09-15 | Takeda Pharmaceutical | Antagonisten des melanin-konzentrierenden hormons |
AU2001256733A1 (en) | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
CN1273451C (zh) | 2000-12-22 | 2006-09-06 | 先灵公司 | 哌啶mch拮抗剂及其治疗肥胖症的用途 |
US6900329B2 (en) | 2001-03-21 | 2005-05-31 | Schering Corporation | MCH antagonists and their use in the treatment of obesity |
JP2005523237A (ja) | 2001-10-01 | 2005-08-04 | 大正製薬株式会社 | Mch受容体アンタゴニスト |
AR036939A1 (es) | 2001-10-25 | 2004-10-13 | Schering Corp | Antagonistas de la hormona de concentracion de melanina (mch) composiciones farmaceuticas, un proceso para su elaboracion y el uso de dichos compuestos, solos o en combinacion, para la elaboracion de un medicamento para el tratamiento de obesidad |
WO2003045918A1 (en) | 2001-11-26 | 2003-06-05 | Schering Corporation | Piperidine-based mch antagonists for treatment of obesity and cns disorders |
CA2468015A1 (en) | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 2-aminoquinoline compounds |
AU2002352868A1 (en) | 2001-11-27 | 2003-06-10 | Merck & Co., Inc. | 4-aminoquinoline compounds |
HUP0500034A2 (hu) | 2001-12-04 | 2005-04-28 | Schering Corporation | N-Aril-N'-(aril-cikloalkil)-karbamid-származékok mint MCH antagonisták és ezeket hatóanyagként tartalmazó gyógyszerkészítmények |
DE10238865A1 (de) | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
AU2003279981A1 (en) * | 2002-10-21 | 2004-05-13 | Janssen Pharmaceutica, N.V. | Treating syndrome x with substituted tetralins and indanes |
CA2521937A1 (en) * | 2003-04-10 | 2004-10-28 | Amgen, Inc. | Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
-
2004
- 2004-09-24 RU RU2006110272/04A patent/RU2006110272A/ru not_active Application Discontinuation
- 2004-09-24 JP JP2006533994A patent/JP2007508303A/ja active Pending
- 2004-09-24 MX MXPA06003654A patent/MXPA06003654A/es unknown
- 2004-09-24 WO PCT/US2004/031631 patent/WO2005033063A2/en not_active Application Discontinuation
- 2004-09-24 EP EP04789086A patent/EP1667958A2/en not_active Withdrawn
- 2004-09-24 KR KR1020067006228A patent/KR20060060047A/ko not_active Application Discontinuation
- 2004-09-24 AU AU2004278352A patent/AU2004278352B2/en not_active Expired - Fee Related
- 2004-09-24 BR BRPI0415051-1A patent/BRPI0415051A/pt not_active IP Right Cessation
- 2004-09-24 SG SG200807343-9A patent/SG146692A1/en unknown
- 2004-09-24 US US10/949,841 patent/US7304065B2/en not_active Expired - Fee Related
- 2004-09-24 CA CA002540826A patent/CA2540826A1/en not_active Abandoned
- 2004-09-24 CN CNA2004800284489A patent/CN101068773A/zh active Pending
- 2004-09-30 AR ARP040103561A patent/AR045958A1/es not_active Application Discontinuation
- 2004-09-30 TW TW093129687A patent/TW200526554A/zh unknown
- 2004-10-01 PE PE2004000964A patent/PE20050475A1/es not_active Application Discontinuation
-
2006
- 2006-03-16 IL IL174370A patent/IL174370A0/en unknown
- 2006-03-17 IS IS8360A patent/IS8360A/is unknown
- 2006-03-31 MA MA28903A patent/MA28079A1/fr unknown
- 2006-04-11 CO CO06035263A patent/CO5690589A2/es not_active Application Discontinuation
- 2006-05-02 NO NO20061953A patent/NO20061953L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MA28079A1 (fr) | 2006-08-01 |
CN101068773A (zh) | 2007-11-07 |
CA2540826A1 (en) | 2005-04-14 |
CO5690589A2 (es) | 2006-10-31 |
US7304065B2 (en) | 2007-12-04 |
TW200526554A (en) | 2005-08-16 |
WO2005033063A2 (en) | 2005-04-14 |
PE20050475A1 (es) | 2005-10-05 |
RU2006110272A (ru) | 2007-11-10 |
BRPI0415051A (pt) | 2006-11-28 |
AU2004278352A1 (en) | 2005-04-14 |
EP1667958A2 (en) | 2006-06-14 |
SG146692A1 (en) | 2008-10-30 |
IS8360A (is) | 2006-03-17 |
AR045958A1 (es) | 2005-11-16 |
US20050075324A1 (en) | 2005-04-07 |
KR20060060047A (ko) | 2006-06-02 |
WO2005033063A3 (en) | 2007-03-22 |
MXPA06003654A (es) | 2006-06-05 |
JP2007508303A (ja) | 2007-04-05 |
IL174370A0 (en) | 2006-08-01 |
AU2004278352B2 (en) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20061953L (no) | Melaninkonsentrerende hormonantagonister | |
EA200900586A1 (ru) | Селективные модуляторы рецепторов эстрогена для лечения вазомоторных симптомов | |
MY159679A (en) | Antibodies binding preferentially human csf1r extracellular domain 4 and their use | |
DK1638551T3 (da) | Immunosuppressive forbindelser og sammensætninger | |
CR9291A (es) | Anticuerpos para interleucina-17f y otros antagonistas de la senalizacion de il-17f, y sus usos | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
ATE469895T1 (de) | Cgrp-rezeptorantagonisten | |
NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
EA201071291A2 (ru) | Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств | |
NZ594140A (en) | C5ar antagonists | |
UA87862C2 (en) | 4-benzylidene-piperidin derivatives | |
ATE399770T1 (de) | Tachykininrezeptorantagonisten | |
NO20053111L (no) | Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. | |
UY27188A1 (es) | Uso de agonistas inversos de gabaa en combinación con agonistas parciales del receptor de nicotina, estrógenos, moduladores selectivos de estrógenos o vitamina e, para el tratamiento de trastornos cognitivos. | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
IL193479A0 (en) | Modulators of muscarinic receptors | |
DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
ATE456953T1 (de) | Behandlung von amyotrophischer lateralsklerose mit pyrimethamin und analoga | |
NO20073369L (no) | Modulatorer av muskarinreseptorer | |
DK2257526T3 (da) | Spiro(5,5)undecan-derivater | |
ECSP034860A (es) | 5-sustituidas-2-arilpiridinas como moduladores del factor 1 de liberación de corticotropina | |
NO20051663L (no) | Fremgangsmater for behandling av neurodegenerasjon | |
EA200800573A1 (ru) | Аминоарильные сульфонамидные производные как функциональные 5-нтлиганды | |
EA200801240A1 (ru) | Новые способы получения производных циклопропиламида | |
EA200602081A1 (ru) | Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |